A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, James L.M. Ferrara, Oleg I. Krijanovski et al.|Blood|2008Cited by 404
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host diseaseJohn E. Levine, James L.M. Ferrara, Sophie Paczesny et al.|Blood|2007Cited by 190
Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-DiseaseJohn Magenau, Sophie Paczesny, Xuemei Qin et al.|Transplantation and Cellular Therapy|2010Cited by 142
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalSung Won Choi, John E. Levine, Carrie L. Kitko et al.|Blood|2008Cited by 141
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Shin Mineishi, Hiromi Tobai et al.|Blood|2011Cited by 57